Document
IPR2017-01103, No. 1019-18 Exhibit - Ex 1019 US Application No 11553,339, Non Final Office Action mailed Apr 28, 2009 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1019-18 Exhibit - Ex 1019 US Application No 11553,339, Non Final Office Action mailed Apr 28, 2009 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1013-12 Exhibit - Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day of Trial, No 06 438 GMS, Dkt 625 D Del June 10, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1013-12 Exhibit - Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day of Trial, No 06 438 GMS, Dkt 625 D Del June 10, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017...
Cite Document
IPR2017-01103, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1023-22 Exhibit - Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1023-22 Exhibit - Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound rev...
Cite Document
IPR2017-01103, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound revised May 20
+ More Snippets
Document
IPR2017-01103, No. 1017-16 Exhibit - Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles ABI 007, Can...
Cite Document
IPR2017-01103, No. 1017-16 Exhibit - Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles ABI 007, Cancer 20
+ More Snippets
Document
IPR2017-01103, No. 1016-15 Exhibit - Ex 1016 Administrative Documents, New Drug Application No 21 660 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1016-15 Exhibit - Ex 1016 Administrative Documents, New Drug Application No 21 660 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 1005-4 Exhibit - Ex 1005 Liversidge et al, US Patent No 5,399,363 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1005-4 Exhibit - Ex 1005 Liversidge et al, US Patent No 5,399,363 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Docket
12/758,413,
U.S. Patent Application
(April 12, 2010)
Cite Docket
COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS, 12/758,413 (U.S. Pat. App.)
+ More Snippets
Document
ABRAXANE, 021660, Letter (Orange Book Aug. 16, 2018)
Cite Document
ABRAXANE, 021660, Letter (Orange Book Aug. 16, 2018)
+ More Snippets
Document
ABRAXANE, 021660, Label (Orange Book Aug. 16, 2018)
Cite Document
ABRAXANE, 021660, Label (Orange Book Aug. 16, 2018)
+ More Snippets
Document
IPR2017-01103, No. 1003-2 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01103, No. 1003-2 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01103, No. 2052-76 Exhibit - Exhibit 2052 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01103, No. 2052-76 Exhibit - Exhibit 2052 (P.T.A.B. Jul. 12, 2017)
+ More Snippets